Healthcare & Life Sciences
Mirati Therapeutics
United Stateswww.mirati.com
Mirati Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
series-c-plus
series-c-plus
Stage
1
Investors
About Mirati Therapeutics
Mirati Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Mirati Therapeutics is a clinical-stage biotechnology company developing targeted oncology therapies, including KRAS G12C inhibitors; its lead program is adagrasib (KRAZATI) for KRAS G12C-mutated cancers.
Explore Mirati Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.